全球避孕药具市场（2023-2030）：按产品（口服药/注射剂）和分销渠道（零售药房/医院）划分的规模、份额、增长分析和预测

全球避孕药具市场规模预计将从2021年的280.9亿美元增长到2022年的299.9亿美元，预测期内復合年增长率为6.5%，到2030年将达到505.9亿美元。预计将增长到1000万美元美元。

由于多种因素，全球避孕市场预计将增长。 性传播疾病（STD）患病率的增加以及无法获得避孕药具和设备的女性人数的增加预计将推动市场增长。 据世界卫生组织（WHO）统计，全球有超过11亿女性需要计划生育，约2.7亿女性避孕需求未得到满足。 预防意外怀孕和提高用户意识的有针对性的计划预计将进一步推动市场增长。

另一方面，对避孕副作用（例如胃部不适、腹胀、头晕和体重增加）的担忧可能会阻碍市场增长。 此外，新兴市场不孕不育的普遍存在和性教育方面的差距可能会阻碍全球避孕市场的增长。 儘管存在这些挑战，由于计划生育以及实施提高认识和预防方案的需求增加，预计在预测期内对避孕药具的需求将会增长。

避孕药具在降低意外怀孕率方面发挥着重要作用，特别是在穷人和低收入人群中。 避孕药具的使用为降低孕产妇死亡率和不安全堕胎做出了重大贡献，并应对全球人口不断增长和性病发病率上升的问题。

各国政府和非政府组织正在加紧努力，通过执行严格的避孕措施来应对人口增长和性传播疾病。 生殖健康研究所和计划生育基金会等各种组织发起了有关正确避孕的公众意识计划。

技术进步是避孕市场势头强劲的一个突出趋势，其中数字避孕是最新的创新。 数字节育在线跟踪您的月经週期并确定您有怀孕风险的天数。 这种数字方法为女性管理不孕症和避免意外怀孕提供了一种新的便捷方式。

在本报告中，我们研究了全球避孕药具市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律和监管环境、市场规模转变和预测以及各种细分市场和地区。编制了单独的细分、竞争格局、主要参与者的概况等。

内容

执行摘要

调查方法

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 驱动程序
  • 机会
  • 制约因素
  • 任务

主要市场洞察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 知识产权分析
• 贸易分析
• 启动分析
• 原材料分析
• 创新矩阵
• 管道产品分析
• 宏观经济指标
• 主要投资分析
• 关键成功因素
• 争用程度

市场动态与展望

• 市场动态
  • 驱动程序
  • 机会
  • 制约因素
  • 任务
• 监管状况
• 波特的分析
• Skyquest 对未来颠覆的特殊洞察

全球避孕市场：按产品

• 市场概况
• 口服避孕药
• 注射避孕药
• 局部避孕药

全球避孕市场：按分销渠道划分

• 市场概况
• 零售药店
• 医院药房
• 诊所
• 在线
• 公众/非政府组织

全球避孕市场：按地区

• 市场概况
• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

竞争格局

• 排名前 5 名的公司比较
• 主要公司的市场定位
• 各大公司的招聘策略
• 关键成功策略
• 近期市场活动
• 主要公司的市场份额

主要公司简介

• Pfizer Inc.
• Bayer AG
• Merck &Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Allergan plc
• Mithra Pharmaceuticals SA
• Afaxys, Inc.
• Reckitt Benckiser Group plc
• CooperSurgical, Inc.
• Agile Therapeutics, Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Johnson &Johnson
• Merck KGaA
• HLL Lifecare Limited
• Church &Dwight Co., Inc.
• Mayer Laboratories, Inc.
• The Female Health Company
• Okamoto Industries, Inc.

Global Contraceptive Drugs Market size was valued at USD 28.09 billion in 2021 and is poised to grow from USD 29.99 billion in 2022 to USD 50.59 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030)

The global contraceptive drugs market is anticipated to experience growth driven by several factors. Increasing incidences of sexually transmitted diseases (STDs) and a rising number of women with no access to contraceptive drugs and devices are expected to boost market growth. According to the World Health Organization, over 1.1 billion women of reproductive age globally require family planning, and approximately 270 million women have unmet contraceptive demand. Targeted programs to prevent unplanned pregnancies and raise user awareness are projected to further drive market growth.

However, the market also faces challenges. Concerns about the side effects of contraceptive drugs, such as stomach upset, bloating, dizziness, and weight gain, could impede market growth. Additionally, infertility prevalence and disparities in sex education in developed countries are potential obstacles to the growth of the global contraceptive drugs market. Despite these challenges, the demand for contraceptive drugs is likely to grow due to the increasing need for family planning and the implementation of awareness and prevention programs during the forecast period.

Segments covered in this report:

Global contraceptive drugs market is segmented on the basis of product, distribution channel and region. On the basis of product, global market is segmented into, oral contraceptive pills, injectable contraceptives and topical contraceptives. On the basis of distribution channel, global market is segmented into, retail pharmacy, hospital pharmacy, clinics, online channel and public channel & NGOs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

Preventing Unwanted Pregnancies: Contraceptive drugs play a crucial role in reducing the prevalence of unintended pregnancies, especially among poor and low-income populations who often rely on traditional methods. Their use contributes significantly to lowering maternal deaths and unsafe abortions, addressing the increasing global population and STD rates.

Government and NGO Initiatives: Governments and non-governmental organizations have intensified efforts to address population growth and STDs by implementing strict birth control measures. Various organizations, such as reproductive health institutes and family planning foundations, have launched public awareness programs on proper contraception.

Restraint

The global contraceptive drugs market faces hindrances due to the adverse effects of long-term birth control pill use. Prolonged consumption, typically over ten years, may result in side effects like headaches, bleeding, and nausea. Furthermore, medications containing oestrogen and progesterone pose an elevated risk of blood clots, potentially leading to heart attacks. These concerns about the safety of long-term use act as a restraint on the market's growth.

Market Trends

Technological advancements are a prominent trend gaining momentum in the contraceptive drugs market, with digital contraception being the latest innovation. Digital contraception involves tracking menstrual cycles online to determine days at risk for pregnancy. In March 2021, the Berlin-based femtech company Clu obtained FDA approval to market Clu Birth Control, an all-digital contraceptive relying on period monitoring data. This contraceptive function combines a user's menstrual cycle data with Clue's prediction algorithm to identify high or low-risk days for pregnancy. Users can then adjust their habits according to their risk tolerance. Clue recommends abstaining from intercourse or using additional forms of contraception, like condoms, during high-risk days. This digital approach offers a new and convenient way for women to manage their fertility and avoid unwanted pregnancies.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Contraceptive Drugs Market by Product

• Market Overview
• Oral contraceptive pills
• Injectable contraceptives
• Topical contraceptives

Global Contraceptive Drugs Market by Distribution Channel

• Market Overview
• Retail pharmacy
• Hospital pharmacy
• Clinics
• Online channel
• Public channel & NGOs

Global Contraceptive Drugs Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments